Aspen Pharmacare Holdings Ltd - Company Profile
Powered by 
All the data and insights you need on Aspen Pharmacare Holdings Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Aspen Pharmacare Holdings Ltd Strategy Report
- Understand Aspen Pharmacare Holdings Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Aspen Pharmacare Holdings Ltd (Aspen) is a provider of specialty and generic pharmaceuticals for the treatment of a range of acute and chronic conditions. The company focuses on thrombosis, anaesthetics and high potency and cytotoxic therapeutic categories. Its manufacturing capabilities cover a range of product types including oral solid dose, semi-solids, liquids, sterile, biological, personal care products and active pharmaceutical ingredients (APIs). The company has a presence in Sub-Saharan Africa, South East Asia, Latin America, Eastern Europe, Western Europe and the Commonwealth of Independent States. Aspen is headquartered in Durban, South Africa.
Headquarters
South Africa
Address
Aspen Place, 9 Rydall Vale Park, Douglas Saunders Drive ,La Lucia Ridge, Durban
Website
www.aspenpharma.com
Telephone
27 31 5808600
No of Employees
8,612
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
APN (JNB)
Revenue (2022)
$2.5B
5.4%
(2022 vs 2021)
EPS
XYZ
Net Income (2022)
XYZ
-19.4%
(2022 vs 2021)
Market Cap*
$5.1B
Net Profit Margin (2022)
XYZ
-23.6%
(2022 vs 2021)
* As of and is in US$
Aspen Pharmacare Holdings Ltd premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Anti-Depressants | Diprivan |
| Anaesthetic | Emla |
| Analgesics (for Pain Relief) | Fraxiparine |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2023 | Contracts/Agreements | In December, Aspen Global Incorporated entered into an agreement to sell four anaesthetic products in Europe to Sandoz. |
| 2023 | Contracts/Agreements | In December, Aspen Global Incorporated entered into an agreement to acquire Chinese business of Sandoz. |
| 2023 | Contracts/Agreements | In September, the company and Aspen SA Operations concluded an agreement with Novo Nordisk for the technical transfer and commercial manufacture of Human Insulins. |
Competitor Comparison
| Key Parameters | Aspen Pharmacare Holdings Ltd | Merck & Co Inc | Pfizer Inc | Novartis AG | AstraZeneca Plc |
|---|---|---|---|---|---|
| Headquarters | South Africa | United States of America | United States of America | Switzerland | United Kingdom |
| City | Durban | Kenilworth | New York | Basel | Cambridge |
| State/Province | - | New Jersey | New York | - | England |
| No. of Employees | 8,612 | 72,000 | 88,000 | 76,057 | 89,900 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Stephen Saad | Chief Executive Officer; Director | Executive Board | 1999 | 58 |
| Sean Capazorio | Director; Chief Financial Officer | Executive Board | 2022 | 57 |
| Lorraine Hill | Group Operating Officer | Senior Management | - | 59 |
| Kuseni Dlamini | Chairman | Non Executive Board | 2012 | 54 |
| Samer Kassem | Chief Executive Officer | Senior Management | 2008 | 47 |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward